Qurgen/复恩特生物 is a biotechnology firm with the slogan "Advancing biotechnology through pioneering protein transport and innovative cell reprogramming技术". Founded in 2016 and based in Iowa, United States, Qurgen specializes in the development of efficient protein-focused in vitro and in vivo cell and tissue reprogramming technologies. The company's offerings include breakthrough protein-targeted transport and efficient in vitro and in vivo protein-induced stem cells, among other patented innovations.
Qurgen recently received a $4.50M Venture Round investment on 13 February 2018 to support its groundbreaking work. With a focus on biotechnology, Qurgen positions itself as a key player in the evolution of innovative solutions for protein transport and cell reprogramming in the industry. This recent investment highlights the potential seen by investors in the company's unique approach and proprietary technologies.
